Status:

COMPLETED

Evaluating the Impact of Reining in Anxiety

Lead Sponsor:

NYU Langone Health

Conditions:

Anxiety

Anxiety Disorder

Eligibility:

All Genders

6-17 years

Phase:

NA

Brief Summary

The purpose of this pilot study is to evaluate the impact of Reining in Anxiety for children with anxiety and their caregivers. A total of up to 80 child/caregiver dyads will be enrolled in the study,...

Detailed Description

Reining in Anxiety is a manualized equine assisted therapy (EAT) for childhood anxiety. The manual and associated materials are being tested in this pilot study, and, if found to be successful, will b...

Eligibility Criteria

Inclusion

  • Caregiver/child dyads where the children are between six and 17 years of age and their caregivers will be enrolled in the study.
  • Children must have a score of 3 or higher as measured by the GAD-2,
  • Children must have a minimum level of functioning as measured by the CGAS of 41 or higher.

Exclusion

  • An inability to provide informed consent

Key Trial Info

Start Date :

February 22 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2021

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT04825756

Start Date

February 22 2021

End Date

September 1 2021

Last Update

February 10 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016